Share the Video:

Phase 2 Multicenter Randomized Placebo-controlled, Double-blind Study to Assess Safety/Efficacy of Inhaled Cannabis in Veterans for PTSD

Sue Sisley, Shane Pennington

Several preliminary studies suggest that cannabis may treat PTSD symptoms. Building off of our previous MJP1 study, this current study aims to re-examine use of inhaled cannabis for treatment of PTSD using a larger sample size, a parallel design, and methods to mitigate placebo response. This Phase 2 multicenter randomized placebo-controlled, double-blind study will assess the safety and efficacy of inhaled cannabis (high THC) versus placebo to manage PTSD symptoms and pain among approximately 360 veterans in an outpatient setting. The study will be conducted in Michigan and three other sites in the U.S.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Ibogaine-Magnesium: the Stanford Traumatic Injury to the CNS (MISTIC) Protocol – A Pilot Study in Special Operations Veterans with Traumatic Brain Injuries

Stanford conducted the first trial of Magnesium-Ibogaine on Special Operations Forces Veterans with traumatic brain injury, showing significant functional improvements and high remission rates for comorbid psychiatric disorders. Further controlled

Nolan Williams

PS2023 Healing for All Indigenous People Policy and Advocacy Psychedelic Science Research Veterans

New Federal Support for Research

Veterans find healing through traditional psychedelics. Learn how veteran communities incorporate psychedelics in ceremonial settings for therapeutic benefits.

Juliana Mercer, SGT(R) Jonathan Lubecky

PS2023 Ancestral Knowledge Healing for All Plant Medicine Psychedelic Science Research Veterans

Veterans and the Journey of Plant Medicine

Veterans find healing through traditional psychedelics, beyond clinical research. Explore how veteran communities use psychedelics in ceremonial settings for therapeutic benefits.

Jesse Gould, Grace Blest-Hopley, Zachary Skiles

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Research Veterans

The Potential of Psychedelic Therapies for Veterans and their Families

Session features the unlikely journey of psychedelic therapy into the VA and updates on current psychedelic research programs.

Marcus Capone, Amber Capone

PS2023 Research

Psychedelic Science 2023 Opening Ceremony

Psychedelic Science 2023 features opening land acknowledgement and addresses by Rick Doblin, Governor Rick Perry, and Governor Jared Polis.

Gov. Rick Perry, Governor Jared Polis, Maya Padilla

PS2023 Harm Reduction Integration Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research

Responding to Crises and Calls with Psychedelic Harm Reduction

Panelists from Zendo Project, Fireside Project, Kosmicare, and Anashim Tovim discuss harm reduction strategies in the psychedelic ecosystem, emphasizing innovation, compassion, and scientific expertise in diverse settings. They provide case

Joshua White, Daniel E Martin, Pinni Baumol, Shirelle Noble, Ben Halper

PS2025 Veterans